R&D
On CB1s as an alternative to GLP-1s, with Punit Dhillon
In a new pharmaphorum podcast, Punit Dhillon, CEO of Skye Bioscience, discusses CB1 inhibitor antibodies in the obesity space.
Digital
Digital transformation as a third lever in the affordability...
Alfred Olivares, global managing partner, healthcare & medtech, at HTEC, discusses how AI and tech can help address the affordability challenge.
R&D
Towards a democratic era of medicine, with Simon Kohl
In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.
R&D
CDMOs: Their crucial role and how to select one, with Sigma ...
Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.
R&D
On US drug shortages and compounding pharmacies, with Shawn ...
Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
